» Articles » PMID: 8939727

P-glycoprotein and Multidrug Resistance

Overview
Publisher Elsevier
Specialties Biology
Genetics
Date 1996 Oct 1
PMID 8939727
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

Although the phenomenon of simultaneous resistance to multiple cytotoxic drugs (multidrug resistance) in cancer cells has been discussed for more than two decades, and the human and mouse genes encoding an energy-dependent transporter (the multidrug transporter or P-glycoprotein) responsible for multidrug resistance were cloned 10 years ago, there is still considerable controversy about the mechanism of action of this efflux pump and its true biological function. This review summarizes the current research on the mechanism of action of the multidrug transporter, including the hydrophobic cleaner and altered partitioning models, the possible function of P-glycoprotein as a chloride and/or ATP channel, the role of phosphorylation in its function and fact and speculation about its physiological role.

Citing Articles

Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments.

Villegas-Vazquez E, Marin-Carrasco F, Reyes-Hernandez O, Baez-Gonzalez A, Bustamante-Montes L, Padilla-Benavides T Front Oncol. 2025; 14:1514120.

PMID: 39876896 PMC: 11772297. DOI: 10.3389/fonc.2024.1514120.


Formononetin Defeats Multidrug-Resistant Cancers by Induction of Oxidative Stress and Suppression of P-Glycoprotein.

Chang Y, Wu I, Sheu M, Lan Y, Hung C Int J Mol Sci. 2024; 25(15).

PMID: 39126039 PMC: 11312483. DOI: 10.3390/ijms25158471.


RN486, a Bruton's Tyrosine Kinase inhibitor, antagonizes multidrug resistance in ABCG2-overexpressing cancer cells.

Dong X, Lu Q, Li Y, Cai C, Teng Q, Lei Z J Transl Int Med. 2024; 12(3):288-298.

PMID: 39081282 PMC: 11284896. DOI: 10.2478/jtim-2024-0011.


Therapeutic potential of extracellular vesicles from diverse sources in cancer treatment.

Lin H, Zhou J, Ding T, Zhu Y, Wang L, Zhong T Eur J Med Res. 2024; 29(1):350.

PMID: 38943222 PMC: 11212438. DOI: 10.1186/s40001-024-01937-x.


Differential Effect of 4-Benzo[] [1, 3]oxazines on the Proliferation of Breast Cancer Cell Lines.

Fraire-Soto I, Araujo-Huitrado J, Granados-Lopez A, Segura-Quezada L, Ortiz-Alvarado R, Herrera M Curr Med Chem. 2024; 31(38):6306-6318.

PMID: 38676529 DOI: 10.2174/0109298673292365240422104456.